| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5729732 | European Urology Focus | 2016 | 9 Pages |
Abstract
A systematic review of the literature showed that Permixon was effective for relieving urinary symptoms due to prostate enlargement and improving urinary flow compared with placebo. Permixon had efficacy similar to tamsulosin and short-term finasteride in relieving urinary symptoms. Permixon was well tolerated and had a very limited impact on sexual function.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Giacomo Novara, Gianluca Giannarini, Antonio Alcaraz, José-M. Cózar-Olmo, Aurelien Descazeaud, Francesco Montorsi, Vincenzo Ficarra,